Search bioRxiv⌕ Search

Biology subjects

Yanagisawa, K.

Publications and source records attributed to Yanagisawa, K..

2 recordsLinked to original sources

CycPeptMP: Enhancing Membrane Permeability Prediction of Cyclic Peptides with Multi-Level Molecular Features and Data Augmentation

Cyclic peptides are versatile therapeutic agents with many excellent properties, such as high binding affinity, minimal toxicity, and the potential to engage challenging protein targets. However, the pharmaceutical utilities of cyclic peptides are limited by their low membrane permeability--an essential indicator of oral bioavailability and intracellular targeting. Current machine learning-based models of cyclic peptide permeability show variable performance due to the limitations of experimental data. Furthermore, these methods use features derived from the whole molecule which are used to predict small molecules and ignore the unique structural properties of cyclic peptides. This study presents CycPeptMP: an accurate and efficient method for predicting the membrane permeability of cyclic peptides. We designed features for cyclic peptides at the atom-, monomer-, and peptide-levels, and seamlessly integrated these into a fusion model using state-of-the-art deep learning technology. Using the latest data, we applied various data augmentation techniques to enhance model training efficiency. The fusion model exhibited excellent prediction performance, with root mean squared error of 0.503 and correlation coefficient of 0.883. Ablation studies demonstrated that all feature levels were essential for predicting membrane permeability and confirmed the effectiveness of augmentation to improve prediction accuracy. A comparison with a molecular dynamics-based method showed that CycPeptMP accurately predicted the peptide permeability, which is otherwise difficult to predict using simulations.

bioinformatics↗

The double-layered structure of amyloid-β assemblage on GM1-containing membranes catalytically promotes fibrillization

Alzheimers disease (AD) is associated with progressive accumulation of amyloid-{beta} (A{beta}) cross-{beta} fibrils in the brain. A{beta} species tightly associated with GM1 ganglioside, a glycosphingolipid abundant in neuronal membranes, promote amyloid fibril formation; therefore, they could be attractive clinical targets. However, the active conformational state of A{beta} in GM1-containing lipid membranes is still unknown. The present solid-state nuclear magnetic resonance study revealed a nonfibrillar A{beta} assemblage characterized by a double-layered antiparallel {beta}-structure specifically formed on GM1 ganglioside clusters. Our data show that this unique assemblage was not transformed into fibrils on GM1-containing membranes, but could promote conversion of monomeric A{beta} into fibrils, suggesting that a solvent-exposed hydrophobic layer provides a catalytic surface evoking A{beta} fibril formation. Our findings will offer structural clues for designing drugs targeting catalytically active A{beta} conformational species for the development of anti-AD therapeutics.

biophysics↗